Such drugs are already in clinical use for the treatment ofrenal anemia in multiple countries, and very recently, the U.S. Foodand Drug Administration approved the PHD inhibitor daprodustat inadults on dialysis suffering for anemia caused by a chronic kidneydisease.1,10. The gene discussed is PDC; the disease is anemia.